Stocktoria
UroGen Pharma Ltd. URGN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2017-05-04
Chart by TradingView
1/9
Piotroski F — financial health
-15.59
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $109.8M | $90.4M | $82.7M | $64.4M | $48.0M |
| Gross profit | $97.3M | $81.5M | $73.4M | $56.7M | $42.9M |
| Operating income | -$124.9M | -$96.8M | -$65.5M | -$79.0M | -$92.3M |
| Net income | -$153.5M | -$126.9M | -$102.2M | -$109.8M | -$110.8M |
| Operating cash flow | -$162.4M | -$96.8M | -$76.4M | -$87.6M | -$84.9M |
| Free cash flow | -$162.7M | -$97.1M | -$76.6M | -$87.8M | -$85.6M |
| Total assets | $200.5M | $285.7M | $178.3M | $135.6M | $119.7M |
| Total liabilities | $305.9M | $294.5M | $243.5M | $225.0M | $111.3M |
| Shareholders' equity | -$105.5M | -$8.8M | -$65.2M | -$89.4M | $8.4M |
| Ratios | |||||
| Gross margin | 88.7% | 90.2% | 88.7% | 88.1% | 89.3% |
| Operating margin | -113.7% | -107.1% | -79.2% | -122.8% | -192.1% |
| Net margin | -139.8% | -140.4% | -123.6% | -170.6% | -230.7% |
| FCF margin | -148.2% | -107.4% | -92.6% | -136.4% | -178.3% |
| Return on assets | -76.6% | -44.4% | -57.3% | -80.9% | -92.5% |
| Return on equity | 145.5% | 1441.3% | 156.8% | 122.9% | -1317.2% |
| Debt / equity | -1.16× | -13.83× | -1.51× | -1.09× | 0.00× |
| Current ratio | 4.01 | 6.01 | 5.42 | 5.39 | 5.11 |
| Revenue growth | 21.4% | 9.3% | 28.5% | 34.0% | 307.2% |
Why these scores methodology →
Piotroski F-score: 1/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -15.59 (distress)
- Working capital / assets 0.696
- Retained earnings / assets -4.788
- EBIT / assets -0.623
- Equity / liabilities -0.345
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001668243 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.